Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials

Timothy Aksamit, Julie V. Philley, David E. Griffith

Research output: Contribution to journalReview article

52 Citations (Scopus)

Abstract

This review will utilize essential questions about nontuberculous mycobacterial (NTM) lung disease to succinctly address important new developments in the pathogenesis, diagnosis and management of NTM lung disease with a focus on practical information and "bottom line" answers. What do I tell my patients who ask, "where did I get this infection" and, "should I take showers"?What is the connection between bronchiectasis and the acquisition of NTM lung infection?What other factors are important in the pathogenesis of NTM lung disease?Why does it seem that am I seeing more new NTM lung disease patients?Why is the diagnosis of NTM lung disease so complicated and does the diagnosis of NTM lung infection obligate specific treatment?Unlike traditional tuberculosis, what is behind the irrelevance of most in vitro susceptibility testing reports for NTM infections?Is there anything new for the management of patients with Mycobacterium avium complex lung disease? How does the radiographic appearance influence treatment?Is there anything new for the management of patients with Mycobacterium abscessus lung disease?What about the management of other NTM respiratory pathogens?Is there a role for the use of macrolide monotherapy for non-cystic fibrosis bronchiectasis?

Original languageEnglish (US)
Pages (from-to)417-425
Number of pages9
JournalRespiratory Medicine
Volume108
Issue number3
DOIs
StatePublished - Mar 2014

Fingerprint

Lung Diseases
Bronchiectasis
Infection
Mycobacterium avium Complex
Lung
Macrolides
Mycobacterium
Tuberculosis
Fibrosis
Therapeutics

Keywords

  • Mycobacterium abscessus
  • Mycobacterium avium Complex (MAC)
  • Nontuberculous mycobacteria

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Nontuberculous mycobacterial (NTM) lung disease : The top ten essentials. / Aksamit, Timothy; Philley, Julie V.; Griffith, David E.

In: Respiratory Medicine, Vol. 108, No. 3, 03.2014, p. 417-425.

Research output: Contribution to journalReview article

Aksamit, Timothy ; Philley, Julie V. ; Griffith, David E. / Nontuberculous mycobacterial (NTM) lung disease : The top ten essentials. In: Respiratory Medicine. 2014 ; Vol. 108, No. 3. pp. 417-425.
@article{3b17b18ba4114ff2a9fecc8663baea49,
title = "Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials",
abstract = "This review will utilize essential questions about nontuberculous mycobacterial (NTM) lung disease to succinctly address important new developments in the pathogenesis, diagnosis and management of NTM lung disease with a focus on practical information and {"}bottom line{"} answers. What do I tell my patients who ask, {"}where did I get this infection{"} and, {"}should I take showers{"}?What is the connection between bronchiectasis and the acquisition of NTM lung infection?What other factors are important in the pathogenesis of NTM lung disease?Why does it seem that am I seeing more new NTM lung disease patients?Why is the diagnosis of NTM lung disease so complicated and does the diagnosis of NTM lung infection obligate specific treatment?Unlike traditional tuberculosis, what is behind the irrelevance of most in vitro susceptibility testing reports for NTM infections?Is there anything new for the management of patients with Mycobacterium avium complex lung disease? How does the radiographic appearance influence treatment?Is there anything new for the management of patients with Mycobacterium abscessus lung disease?What about the management of other NTM respiratory pathogens?Is there a role for the use of macrolide monotherapy for non-cystic fibrosis bronchiectasis?",
keywords = "Mycobacterium abscessus, Mycobacterium avium Complex (MAC), Nontuberculous mycobacteria",
author = "Timothy Aksamit and Philley, {Julie V.} and Griffith, {David E.}",
year = "2014",
month = "3",
doi = "10.1016/j.rmed.2013.09.014",
language = "English (US)",
volume = "108",
pages = "417--425",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Nontuberculous mycobacterial (NTM) lung disease

T2 - The top ten essentials

AU - Aksamit, Timothy

AU - Philley, Julie V.

AU - Griffith, David E.

PY - 2014/3

Y1 - 2014/3

N2 - This review will utilize essential questions about nontuberculous mycobacterial (NTM) lung disease to succinctly address important new developments in the pathogenesis, diagnosis and management of NTM lung disease with a focus on practical information and "bottom line" answers. What do I tell my patients who ask, "where did I get this infection" and, "should I take showers"?What is the connection between bronchiectasis and the acquisition of NTM lung infection?What other factors are important in the pathogenesis of NTM lung disease?Why does it seem that am I seeing more new NTM lung disease patients?Why is the diagnosis of NTM lung disease so complicated and does the diagnosis of NTM lung infection obligate specific treatment?Unlike traditional tuberculosis, what is behind the irrelevance of most in vitro susceptibility testing reports for NTM infections?Is there anything new for the management of patients with Mycobacterium avium complex lung disease? How does the radiographic appearance influence treatment?Is there anything new for the management of patients with Mycobacterium abscessus lung disease?What about the management of other NTM respiratory pathogens?Is there a role for the use of macrolide monotherapy for non-cystic fibrosis bronchiectasis?

AB - This review will utilize essential questions about nontuberculous mycobacterial (NTM) lung disease to succinctly address important new developments in the pathogenesis, diagnosis and management of NTM lung disease with a focus on practical information and "bottom line" answers. What do I tell my patients who ask, "where did I get this infection" and, "should I take showers"?What is the connection between bronchiectasis and the acquisition of NTM lung infection?What other factors are important in the pathogenesis of NTM lung disease?Why does it seem that am I seeing more new NTM lung disease patients?Why is the diagnosis of NTM lung disease so complicated and does the diagnosis of NTM lung infection obligate specific treatment?Unlike traditional tuberculosis, what is behind the irrelevance of most in vitro susceptibility testing reports for NTM infections?Is there anything new for the management of patients with Mycobacterium avium complex lung disease? How does the radiographic appearance influence treatment?Is there anything new for the management of patients with Mycobacterium abscessus lung disease?What about the management of other NTM respiratory pathogens?Is there a role for the use of macrolide monotherapy for non-cystic fibrosis bronchiectasis?

KW - Mycobacterium abscessus

KW - Mycobacterium avium Complex (MAC)

KW - Nontuberculous mycobacteria

UR - http://www.scopus.com/inward/record.url?scp=84896697001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896697001&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2013.09.014

DO - 10.1016/j.rmed.2013.09.014

M3 - Review article

C2 - 24484653

AN - SCOPUS:84896697001

VL - 108

SP - 417

EP - 425

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

IS - 3

ER -